BIOMAT Database Logo BIOMAT Database Logo

Tacrolimus (FK506) versus cyclosporin in prevention of liver allograft rejection. 1994

R Moore, and R Lord

UI MeSH Term Description Entries
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal
D016031 Liver Transplantation The transference of a part of or an entire liver from one human or animal to another. Grafting, Liver,Hepatic Transplantation,Liver Transplant,Transplantation, Hepatic,Transplantation, Liver,Hepatic Transplantations,Liver Grafting,Liver Transplantations,Liver Transplants,Transplant, Liver
D016559 Tacrolimus A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro. Anhydrous Tacrolimus,FK-506,FK506,FR-900506,Prograf,Prograft,Tacrolimus Anhydrous,Anhydrous, Tacrolimus,FK 506,FR 900506,FR900506,Tacrolimus, Anhydrous
D016572 Cyclosporine A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). Cyclosporin A,Ciclosporin,CsA-Neoral,CyA-NOF,Cyclosporin,Cyclosporine A,Neoral,OL 27-400,Sandimmun,Sandimmun Neoral,Sandimmune,CsA Neoral,CsANeoral,CyA NOF,OL 27 400,OL 27400

Related Publications

R Moore, and R Lord
Tacrolimus (FK506) versus cyclosporin in prevention of liver allograft rejection.
October 1994, Lancet (London, England),
R Moore, and R Lord
Tacrolimus (FK506) versus cyclosporin in prevention of liver allograft rejection.
October 1994, Lancet (London, England),
R Moore, and R Lord
Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group.
August 1994, Lancet (London, England),
R Moore, and R Lord
Tacrolimus for prevention of liver allograft rejection: clinical trials and tribulations.
November 1995, Lancet (London, England),
R Moore, and R Lord
FK506 conversion for intractable rejection of the liver allograft.
January 1993, Transplant international : official journal of the European Society for Organ Transplantation,
R Moore, and R Lord
Cyclosporin versus tacrolimus for liver transplanted patients.
October 2006, The Cochrane database of systematic reviews,
R Moore, and R Lord
Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat.
June 2003, Transplantation,
R Moore, and R Lord
Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group.
August 1997, Transplantation,
R Moore, and R Lord
Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation.
January 1998, Transplantation,
R Moore, and R Lord
[Glucose intolerance induced by tacrolimus (FK506), cyclosporin A].
February 2005, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!